Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,498
Recruiting: 782
Ph III recruiting: 85
Growth YoY: +17.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 251–257 of 257 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06391190	Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer	recruiting	Phase 1 / Phase 2	20	RenJi HospitalOTHER	1	Apr 30, 2024	clinicaltrials
NCT06265025	GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors	recruiting	Phase 1 / Phase 2	125	GeneMedicine Co., Ltd.INDUSTRY	1	Mar 21, 2024	clinicaltrials